Bristol-Myers Squibb Company
BMYCompany Overview
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Country
US
Market Cap
$104.16B
Last Fiscal Year
2023
Final Shariah Status
Failed
Compliance Analysis Overview
Shariah Compliance Benchmarks:
- Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
- Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
Business Compliance
0.00%
passed
Liabilities Compliance
39.80%
failed
Final Shariah Status
Failed
This stock does not meet all Shariah compliance criteria according to AAOIFI standards.
Stock Information
| Name | Bristol-Myers Squibb Company |
| Ticker | BMY |
| Main Business | Biopharmaceutical company |
| Type | Securities |
| Industry | Drug Manufacturers—General |
| Country | US |
| Market Cap | $104.16 B |
Shariah Analysis Breakdown
Business compliance Breakdown
| Revenue Segment | Value ($M) | Non-Compliant ($M) | Reason |
|---|---|---|---|
| Net product sales | $44,671.0 | $0.0 | - |
| Alliance and other revenues | $1,488.0 | $0.0 | - |
| Total | $46,159.0 | $0.0 | 0.00% (passed) |
Liabilities Compliance Breakdown
| Liability Item | Value ($M) | % of Market Cap |
|---|---|---|
| current debt and capital lease obligation | $3,280,000,000.0 | 3.15% |
| long term debt and capital lease obligation | $38,180,000,000.0 | 36.66% |
| Total Interest-Bearing Debt | $41,460,000,000.0 | 39.80% |
| Market Capitalization | $104,159,300,000.0 | 100.00% |
| Compliance Status | Threshold: 33% | failed |